Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization

• Published in: eLife 2023-04, Vol.12
• Main Authors: Gormley, Mark, Dudding, Tom, Thomas, Steven J, Tyrrell, Jessica, Ness, Andrew R, Pring, Miranda, Legge, Danny, Davey Smith, George, Richmond, Rebecca C, Vincent, Emma E, Bull, Caroline
• Format: Article
• Language: English
• Subjects: Diabetes Mellitus, Type 2 - epidemiology; Diabetes Mellitus, Type 2 - genetics; Genetics and Genomics; Genome-Wide Association Study; head and neck cancer; Humans; Hypertension; Mendelian randomization; Mendelian Randomization Analysis; metabolic traits; Obesity; oral cancer; oropharyngeal cancer; Oropharyngeal Neoplasms - epidemiology; Oropharyngeal Neoplasms - genetics; Polymorphism, Single Nucleotide; Risk Factors
• ISSN: 2050-084X; 2050-084X
• DOI: 10.7554/eLife.82674

A recent World Health Organization report states that at least 40% of all cancer cases may be preventable, with smoking, alcohol consumption, and obesity identified as three of the most important modifiable lifestyle factors. Given the significant decline in smoking rates, particularly within developed countries, other potentially modifiable risk factors for head and neck cancer warrant investigation. Obesity and related metabolic disorders such as type 2 diabetes (T2D) and hypertension have been associated with head and neck cancer risk in multiple observational studies. However, adiposity has also been correlated with smoking, with bias, confounding or reverse causality possibly explaining these findings. To overcome the challenges of observational studies, we conducted two-sample Mendelian randomization (inverse variance weighted [IVW] method) using genetic variants which were robustly associated with adiposity, glycaemic and blood pressure traits in genome-wide association studies (GWAS). Outcome data were taken from the largest available GWAS of 6034 oral and oropharyngeal cases, with 6585 controls. We found limited evidence of a causal effect of genetically proxied body mass index (BMI; OR IVW = 0.89, 95% CI 0.72-1.09, p = 0.26 per 1 standard deviation in BMI [4.81kg/m ]) on oral and oropharyngeal cancer risk. Similarly, there was limited evidence for related traits including T2D and hypertension. Small effects cannot be excluded given the lack of power to detect them in currently available GWAS.